R-loop-induced DNA damage during immunoglobulin class switch recombination
免疫球蛋白类别转换重组过程中 R 环诱导的 DNA 损伤
基本信息
- 批准号:10457910
- 负责人:
- 金额:$ 31.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-08-05 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelAntibodiesAutomobile DrivingB-LymphocytesBiologyCell physiologyCellsCellular biologyChromatinChromosome Fragile SitesCollaborationsComplexDNADNA DamageDNA Double Strand BreakDNA RepairDNA Repair GeneDNA Repair PathwayDNA Sequence RearrangementDefectDevelopmentDissectionEnzymesEventExcisionFrequenciesG22P1 geneGene RearrangementGenerationsGenetic ProcessesGenetic TranscriptionGenomic InstabilityGenomicsGoalsHeavy-Chain ImmunoglobulinsHumanHybridsHypersensitivityIGH@ gene clusterImmunoglobulin Class SwitchingImmunoglobulin Switch RecombinationImmunoglobulinsLigaseLocationLymphocyteLymphomagenesisMalignant NeoplasmsMalignant lymphoid neoplasmMapsMediatingMetabolismMolecularMonitorMusMutationNonhomologous DNA End JoiningOncogenicPathway interactionsPharmaceutical PreparationsPlayProductionProteinsRAD52 geneRNARecurrenceResearch PersonnelRibonucleasesRibonucleotidesRoleSETX geneSiteStructureTechniquesTestingTranscriptional ActivationWorkcancer cellcancer therapychromosome fusiondefined contributionexperiencegenome-widegenomic locushelicasehomologous recombinationinhibitorinnovationinsertion/deletion mutationinsightmouse modelmutantnovelnucleasepublic health relevancerecruitrepairedreplication stresssynergismtumorigenesis
项目摘要
Project Summary/Abstract
Class switch recombination (CSR) is a genetic process where a B cell switches antibody isotype
production through site-specific intra-chromosomal DNA rearrangement stimulated by the formation
of DNA double-strand breaks (DSBs) at the immunoglobulin heavy chain (IgH) locus. DSBs are
normally repaired by the non-homologous end-joining (NHEJ) and alternative-end joining (alt-EJ)
DNA repair pathways. During CSR, DSB formation is highly regulated involving a complex interplay of
transcriptional activation, protein recruitment and chromatin reorganization. Understanding the factors
regulating DSB formation and repair has a high impact on lymphomagenesis. R loops are three
stranded RNA:DNA hybrid structures formed at IgH during CSR. While R loops are implicated in
promoting DSB formation at IgH, their role in class switch recombination remains undefined. We find
that mice defective for R loop removal are proficient at class switch recombination, however B cells
contain unrepaired breaks and chromosome fusions at IgH. Recurrent oncogenic translocations
involving IgH distinguish many human lymphoid malignancies. These translocations originate from
mis-repaired DNA double stand breaks (DSBs) generated during normal lymphocyte development.
Our goal is to determine how persistent R loops impede DNA repair during CSR, and the role R loop
metabolism plays in suppressing genome instability at IgH. We hypothesize that persistent R loops
block efficient DNA repair by non-homologous end joining at the immunoglobulin heavy chain
locus during class switch recombination, leading to persistent, unrepaired breaks. To test this
hypothesis, two mouse models will be employed: the SETX mutant lacks the Senataxin (SETX)
helicase that unwinds R loops;; and Rnaseh2b is defective for the RNase H2 nuclease that specifically
digests the RNA component of R loops (RNH2B). We will functionally dissect the consequences of
aberrant R loop formation on DNA repair and chromosome fusions arising during CSR in SETX-/-,
RNH2Bf/f, and SETX-/- RNH2Bf/f cells (Aim 1). To define the impact persistent R loops have on NHEJ,
we will characterize DNA repair protein recruitment in SETX-/-, RNH2Bf/f, and SETX-/- RNH2Bf/f cells
(Aim 2). We will also identify genomic loci involved in IgH translocations using high-throughput
genome-wide translocation sequencing (HTGTS-Seq), in collaboration with Dr. Feyredoun
Hormozdiari. Finally, we will define the molecular pathways driving the frequent chromosome fusions
observed in SETX-/- RNH2Bf/f cells (Aim 3). Our work will define how persistent R loops interfere with
class switch recombination, leading to unrepaired breaks, and will uncover the molecular
mechanisms promoting chromosome fusions at IgH. Enzymes regulating R loop metabolism will also
provide an attractive target for developing novel cancer treatment.
项目摘要/摘要
类别转换重组 (CSR) 是 B 细胞转换抗体同种型的遗传过程
通过由形成刺激的位点特异性染色体内 DNA 重排产生
免疫球蛋白重链 (IgH) 位点处的 DNA 双链断裂 (DSB)。 DSB 是
通常由非同源末端连接 (NHEJ) 和替代末端连接 (alt-EJ) 修复
DNA 修复途径。 在 CSR 期间,DSB 的形成受到严格监管,涉及以下因素的复杂相互作用:
转录激活、蛋白质募集和染色质重组。 了解因素
调节 DSB 形成和修复对淋巴瘤发生有很大影响。 R 循环有 3 个
在 CSR 过程中,IgH 处形成链状 RNA:DNA 杂合结构。 While R 循环涉及
促进 IgH 处 DSB 的形成,但它们在类别转换重组中的作用仍不确定。 我们发现
R 环去除缺陷的小鼠擅长类别转换重组,但是 B 细胞
IgH 处含有未修复的断裂和染色体融合。 复发性致癌易位
涉及 IgH 来区分许多人类淋巴恶性肿瘤。 这些易位源自
正常淋巴细胞发育过程中产生的错误修复 DNA 双链断裂 (DSB)。
我们的目标是确定 R 环在 CSR 过程中如何阻碍 DNA 修复,以及 R 环的作用
新陈代谢在抑制 IgH 基因组不稳定性方面发挥着作用。 我们假设持久的 R 循环
通过免疫球蛋白重链上的非同源末端连接来阻断有效的 DNA 修复
类切换重组期间的位点,导致持续的、未修复的断裂。 要测试这个
假设,将采用两种小鼠模型:SETX 突变体缺乏 Senataxin (SETX)
解旋 R 环的解旋酶;;Rnaseh2b 对 RNase H2 核酸酶有缺陷,该核酸酶专门
消化 R 环 (RNH2B) 的 RNA 成分。 我们将从功能上剖析以下后果
SETX-/- 中 CSR 期间出现的 DNA 修复和染色体融合异常 R 环形成,
RNH2Bf/f 和 SETX-/- RNH2Bf/f 细胞(目标 1)。 为了定义持续 R 环对 NHEJ 的影响,
我们将描述 SETX-/-、RNH2Bf/f 和 SETX-/- RNH2Bf/f 细胞中 DNA 修复蛋白招募的特征
(目标 2)。 我们还将使用高通量鉴定参与 IgH 易位的基因组位点
与 Feyredoun 博士合作进行全基因组易位测序 (HTGTS-Seq)
霍尔莫兹迪亚里。 最后,我们将定义驱动频繁染色体融合的分子途径
在 SETX-/- RNH2Bf/f 细胞中观察到(目标 3)。 我们的工作将定义持久 R 循环如何干扰
类别转换重组,导致未修复的断裂,并将揭示分子
IgH 促进染色体融合的机制。 调节 R 环代谢的酶也会
为开发新型癌症治疗方法提供了一个有吸引力的目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jacqueline Barlow其他文献
Jacqueline Barlow的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jacqueline Barlow', 18)}}的其他基金
R-loop-induced DNA damage during immunoglobulin class switch recombination
免疫球蛋白类别转换重组过程中 R 环诱导的 DNA 损伤
- 批准号:
10217205 - 财政年份:2019
- 资助金额:
$ 31.4万 - 项目类别:
R-loop-induced DNA damage during immunoglobulin class switch recombination
免疫球蛋白类别转换重组过程中 R 环诱导的 DNA 损伤
- 批准号:
10581441 - 财政年份:2019
- 资助金额:
$ 31.4万 - 项目类别:
R-loop-induced DNA damage during immunoglobulin class switch recombination
免疫球蛋白类别转换重组过程中 R 环诱导的 DNA 损伤
- 批准号:
10673639 - 财政年份:2019
- 资助金额:
$ 31.4万 - 项目类别:
R-loop-induced DNA damage during immunoglobulin class switch recombination
免疫球蛋白类别转换重组过程中 R 环诱导的 DNA 损伤
- 批准号:
10294876 - 财政年份:2019
- 资助金额:
$ 31.4万 - 项目类别:
Characterization of replication-mediated DNA damage in B lymphocytes
B 淋巴细胞复制介导的 DNA 损伤的表征
- 批准号:
9020219 - 财政年份:2015
- 资助金额:
$ 31.4万 - 项目类别:
Characterization of replication-mediated DNA damage in B lymphocytes
B 淋巴细胞复制介导的 DNA 损伤的表征
- 批准号:
8764124 - 财政年份:2015
- 资助金额:
$ 31.4万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 31.4万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 31.4万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 31.4万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 31.4万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 31.4万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 31.4万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 31.4万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 31.4万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 31.4万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 31.4万 - 项目类别:














{{item.name}}会员




